Back
Biomarin Pharmaceutical Vs. Nebius Group NV Industry Stock Comparison
Buy
64
BMRN
Biomarin Pharmaceutical
Last Price:
$67.09
Seasonality Move:
9.08%
Sell
42
NBIS
Nebius Group NV
Last Price:
$31.18
Seasonality Move:
-3.02%
Buy
64
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
-
The current Biomarin Pharmaceutical [BMRN] share price is $67.07. The Score for BMRN is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
BMRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Nebius Group NV (NBIS)
is a Sell
Is Nebius Group NV a Buy, Sell or Hold?
-
The current Nebius Group NV [NBIS] share price is $31.22. The Score for NBIS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
NBIS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $67.07The current trend is relatively stagnant and BMRN is experiencing slight selling pressure.
NBIS Stock Price Chart
What is Nebius Group NV's stock price today?
-
The Nebius Group NV share price today is $31.22Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBIS is experiencing selling pressure, which indicates risk of future bearish movement.
BMRN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.14 | Buy |
Relative Strength Index (14 RSI): | 54.86 | Buy |
Chaikin Money Flow: | -303765 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (65.17 - 66.95) | Buy |
Bollinger Bands (100): | (62.94 - 81.78) | Sell |
NBIS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.13 | Buy |
Relative Strength Index (14 RSI): | 59.34 | Buy |
Chaikin Money Flow: | -3309685 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.59 - 32.71) | Buy |
Bollinger Bands (100): | (17.22 - 26.82) | Buy |
BMRN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 66.51 | Buy |
20-day SMA: | 66.23 | Buy |
50-day SMA: | 66.02 | Buy |
200-day SMA: | 78.08 | Sell |
8-day EMA: | 66.48 | Buy |
20-day EMA: | 66.2 | Buy |
50-day EMA: | 67.28 | Sell |
200-day EMA: | 76.12 | Sell |
NBIS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.89 | Buy |
20-day SMA: | 30.03 | Buy |
50-day SMA: | 25.12 | Buy |
200-day SMA: | 20.48 | Buy |
8-day EMA: | 29.56 | Buy |
20-day EMA: | 28.7 | Buy |
50-day EMA: | 26.04 | Buy |
200-day EMA: | 21.62 | Buy |
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.88 per share, and an increase next year of $1.01 per share.
Nebius Group NV Earnings Growth & NBIS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Biomarin Pharmaceutical Technical Analysis
Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nebius Group NV Technical Analysis
Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |